MX2009008281A - Materiales de ion metalico de poli-oxo-hidroxi modificados con ligando, sus usos y procesos para su preparacion. - Google Patents

Materiales de ion metalico de poli-oxo-hidroxi modificados con ligando, sus usos y procesos para su preparacion.

Info

Publication number
MX2009008281A
MX2009008281A MX2009008281A MX2009008281A MX2009008281A MX 2009008281 A MX2009008281 A MX 2009008281A MX 2009008281 A MX2009008281 A MX 2009008281A MX 2009008281 A MX2009008281 A MX 2009008281A MX 2009008281 A MX2009008281 A MX 2009008281A
Authority
MX
Mexico
Prior art keywords
processes
metal ion
modified poly
preparation
hydroxy metal
Prior art date
Application number
MX2009008281A
Other languages
English (en)
Spanish (es)
Inventor
Jonathan Joseph Powell
Sylvaine Francoise Aline Bruggraber
Nuno Jorge Rodrigues Faria
Dora Isabel Amaral Pereira
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0702270.0A external-priority patent/GB0702270D0/en
Application filed by Medical Res Council filed Critical Medical Res Council
Publication of MX2009008281A publication Critical patent/MX2009008281A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/76—Metal complexes of amino carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F11/00—Compounds containing elements of Groups 6 or 16 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G99/00—Subject matter not provided for in other groups of this subclass

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Cosmetics (AREA)
  • Catalysts (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
MX2009008281A 2007-02-06 2008-02-06 Materiales de ion metalico de poli-oxo-hidroxi modificados con ligando, sus usos y procesos para su preparacion. MX2009008281A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88838607P 2007-02-06 2007-02-06
GBGB0702270.0A GB0702270D0 (en) 2007-02-06 2007-02-06 Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
PCT/GB2008/000408 WO2008096130A1 (en) 2007-02-06 2008-02-06 Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation

Publications (1)

Publication Number Publication Date
MX2009008281A true MX2009008281A (es) 2009-08-25

Family

ID=39204358

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008281A MX2009008281A (es) 2007-02-06 2008-02-06 Materiales de ion metalico de poli-oxo-hidroxi modificados con ligando, sus usos y procesos para su preparacion.

Country Status (15)

Country Link
US (1) US8058462B2 (cg-RX-API-DMAC7.html)
EP (1) EP2125847B1 (cg-RX-API-DMAC7.html)
JP (1) JP5756598B2 (cg-RX-API-DMAC7.html)
KR (1) KR101514470B1 (cg-RX-API-DMAC7.html)
AU (1) AU2008212653B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0807212B1 (cg-RX-API-DMAC7.html)
CA (1) CA2676146C (cg-RX-API-DMAC7.html)
CY (1) CY1116590T1 (cg-RX-API-DMAC7.html)
EA (1) EA019635B1 (cg-RX-API-DMAC7.html)
GB (1) GB2451713B (cg-RX-API-DMAC7.html)
HR (1) HRP20150944T1 (cg-RX-API-DMAC7.html)
IL (1) IL199901A (cg-RX-API-DMAC7.html)
MX (1) MX2009008281A (cg-RX-API-DMAC7.html)
PL (1) PL2125847T3 (cg-RX-API-DMAC7.html)
WO (1) WO2008096130A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2451713B (en) 2007-02-06 2009-12-16 Medical Res Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
GB0814326D0 (en) * 2008-08-05 2008-09-10 Medical Res Council Phosphate binding materials and their uses
GB201101299D0 (en) 2011-01-25 2011-03-09 Medical Res Council Oxygen sensors and their uses
GB201507002D0 (en) * 2015-04-24 2015-06-10 Medical Res Council Copper Oxo-hydroxide nanoparticles and their uses as biocidal agents
GB201517893D0 (en) * 2015-10-09 2015-11-25 Medical Res Council Methods for producing carboxylate ligand modified ferric iron hydroxide colloids
WO2017167963A1 (en) * 2016-03-31 2017-10-05 Medical Research Council Methods for producing ferric maltol compositions from ligand modified and ligand coated ferric hydroxides
WO2017167970A1 (en) 2016-03-31 2017-10-05 Medical Research Council Methods for producing ferric maltol compositions from ferrous hydroxides
US11007217B2 (en) 2016-08-10 2021-05-18 United Kingdom Research And Innovation Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy
HRP20250225T1 (hr) 2017-09-11 2025-05-09 Pharmacosmos Holding A/S Kompleksni spojevi željeza za terapijsku uporabu
GB202005054D0 (en) * 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
WO2022061065A1 (en) * 2020-09-17 2022-03-24 Doyle Robert P Complexes of magnesium maltol (3-hydroxy-2-methyl-4h-pyran-4-one) for oral supplementation
EP4380581A1 (en) 2021-08-03 2024-06-12 Pharmacosmos Holding A/S Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL264270A (cg-RX-API-DMAC7.html)
US2575347A (en) 1949-07-14 1951-11-20 Interchem Corp Metallo organic compounds
GB959282A (en) 1959-08-19 1964-05-27 Hardman & Holden Ltd Improvements relating to organic aluminium compounds
US3076798A (en) 1961-02-23 1963-02-05 Hausmann Lab Ltd Process for preparing a ferric hydroxide polymaltose complex
US3679377A (en) 1970-02-17 1972-07-25 Union Oil Co Iron complexes containing aquo,sulfate and hydroxyl ligands
US3821192A (en) 1971-08-18 1974-06-28 Central Pharmacal Co Process for preparing an iron-saccharide complex
US4162986A (en) * 1977-06-20 1979-07-31 Mooney Chemicals, Inc. Oil-soluble high metal content transitional metal organic oxy, hydroxy, complexes
US4137359A (en) * 1977-10-31 1979-01-30 Mooney Chemicals, Inc. Elastomers with improved metal adhesion
DE4239442C2 (de) 1992-11-24 2001-09-13 Sebo Gmbh Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten
US6177581B1 (en) * 1999-10-12 2001-01-23 The Dow Chemical Company Mixed-metal chelates and process for the preparation thereof
US20030049284A1 (en) 2001-09-05 2003-03-13 Boccio Jose Ruben Method of increasing the solubility of alphahydrocarboxilic salts, and products obtained by the method
EP1434869B1 (en) 2001-10-08 2010-12-15 Purac Biochem N.V. Method for preparing calcium gluconate
CA2473934C (en) * 2002-01-24 2011-01-04 William Marsh Rice University Ferroxanes, membranes and ceramics made therefrom
US7994217B2 (en) 2002-05-02 2011-08-09 Xanodyne Pharmaceuticals, Inc. Prenatal multivitamin/multimineral supplement
GB0211500D0 (en) 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US6706904B1 (en) 2002-12-04 2004-03-16 Albion International, Inc. Dimetalhydroxy malates
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
US7964568B2 (en) 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
US7179939B2 (en) 2004-03-16 2007-02-20 Navinta Llc Sodium ferric gluconate complexes and method of manufacture thereof
WO2005094202A2 (en) 2004-03-16 2005-10-13 Navinta, Llc Iron sucrose complexes and method of manufacture thereof
RU2007117147A (ru) 2004-10-08 2008-11-20 Юнилевер Н.В. (Nl) Комплекс железа
DE202005014332U1 (de) 2005-09-09 2006-01-19 Institut für Oberflächenmodifizierung e.V. Metallorganisches Nanopulver
GB2451713B (en) 2007-02-06 2009-12-16 Medical Res Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
TWI468167B (zh) 2007-11-16 2015-01-11 威佛（國際）股份有限公司 藥學組成物
GB0814326D0 (en) 2008-08-05 2008-09-10 Medical Res Council Phosphate binding materials and their uses

Also Published As

Publication number Publication date
US20080188555A1 (en) 2008-08-07
CA2676146A1 (en) 2008-08-14
CY1116590T1 (el) 2017-03-15
GB2451713B (en) 2009-12-16
US8058462B2 (en) 2011-11-15
IL199901A0 (en) 2010-04-15
BRPI0807212A2 (pt) 2014-06-17
HK1138598A1 (en) 2010-08-27
KR101514470B1 (ko) 2015-04-22
GB0802214D0 (en) 2008-03-12
EA200970718A1 (ru) 2010-02-26
HRP20150944T1 (hr) 2015-10-09
EP2125847B1 (en) 2015-06-17
AU2008212653A1 (en) 2008-08-14
WO2008096130A1 (en) 2008-08-14
CA2676146C (en) 2016-08-09
JP2010520856A (ja) 2010-06-17
EP2125847A1 (en) 2009-12-02
GB2451713A (en) 2009-02-11
AU2008212653B2 (en) 2012-05-24
IL199901A (en) 2014-11-30
PL2125847T3 (pl) 2015-12-31
BRPI0807212B1 (pt) 2022-01-11
EA019635B1 (ru) 2014-05-30
JP5756598B2 (ja) 2015-07-29
KR20090121281A (ko) 2009-11-25

Similar Documents

Publication Publication Date Title
MX2009008281A (es) Materiales de ion metalico de poli-oxo-hidroxi modificados con ligando, sus usos y procesos para su preparacion.
WO2009111159A3 (en) Biocompatible materials containing stable complexes of tsg-6 and hyaluronan and method of using same
IL218317A (en) Use of 15-il polypeptide preparations and 15-il complexes for the preparation of cancer drugs
WO2007002662A3 (en) Anti-inflammatory, radioprotective, and longevity enhancing capabilities of cerium oxide nanoparticles
MX2009004707A (es) Piridina carboxamides como inhibidores 11-beta-hsd1.
EP2051572A3 (en) Housing for electronic components
WO2007043048A3 (en) Self-assembled fmoc-ff hydrogels
EP2145902A3 (en) Tyrosine phosphorylation sites and antibodies specific for them
WO2008140594A3 (en) Peptide nanoparticles and uses therefor
IL185808A0 (en) Amide-substituted 8-n-benzimidazoles, metohd for the production thereof, and use of the same as medicaments
MY154217A (en) Ingestible circuitry
WO2007124302A3 (en) Bone graft composition
WO2010083385A3 (en) Compounds for reducing drug resistance and uses thereof
MY156951A (en) Micromirs
EP1990059A3 (en) methods for treating cancer
WO2009149339A3 (en) P53 activator peptides
WO2008151022A3 (en) Nucleic acid nanoparticles and uses therefor
WO2009100716A3 (de) Implantierbare nanopartikel-enthaltende produkte
WO2007098127A3 (en) Compositions for treating wounds and processes for their preparation
PL2234947T3 (pl) Produkt oparty na glicerynie, sposób jego otrzymywania i jego zastosowanie do wytwarzania dichloropropanolu
WO2007005912A3 (en) Compositions for treating wounds and processes for their preparation
WO2010065329A3 (en) Nanoparticles for cancer treatment
IL184700A0 (en) Method of providing readily available cellular material derived from cord blood, and composition thereof
WO2009106819A3 (en) Biological materials and uses thereof
MY162640A (en) Thioninium compounds and their use

Legal Events

Date Code Title Description
FG Grant or registration